The state of Utah currently has 25 active clinical trials seeking participants for Hypertension research studies. These trials are conducted in various cities, including Salt Lake City, Murray, Ogden and West Jordan.
Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension
NCT04039464
Recruiting
The investigators' central hypothesis is that early combination therapy with two PAH-specific oral therapies that have been shown to be well tolerated in the pediatric population, sildenafil and bosentan, will result in better World Health Organization (WHO) functional class at 12 months after initiation of PAH treatment than therapy with sildenafil alone.
Gender:
ALL
Ages:
Between 3 months and 18 years
Trial Updated:
10/09/2024
Locations: University of Utah Hospital, Salt Lake City, Utah
Conditions: Pediatric Pulmonary Hypertension
Register for Updates